TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Allergan plc (NYSE:AGN) Investor Securities Class Action Lawsuit 06/30/2017

  • If you sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Company
Allergan, Inc.
Security
NYSE: AGN

Case Name
Allergan Shareholder Class Action Lawsuit 06/30/2017
Type of Lawsuit
Shareholder Class Action
Court of Filing
U.S. District Court for the Central District of California

Class Period Begin
Class Period End
Deadline To File for Lead
You must register or login to receive notifications.

Click here to subscribe to Allergan, Inc..
Summary

June 30, 2017 (Shareholders Foundation) - An investor in shares of Allergan plc (NYSE:AGN) filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by Allergan plc in connection with certain allegedly false and misleading statements made between February 25, 2014 through April 21, 2014.

According to the complaint the plaintiff alleges on behalf of investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) common shares between February 25, 2014 through April 21, 2014, that the defendants violated Federal Securities Laws.

More specifically, the plaintiff claims that between February 25, 2014 through April 21, 2014, certain Defendants traded on material non-public information regarding the proposed acquisition, and as a result, investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan, Inc between February 25, 2014 through April 21, 2014 did so at prices that did not reflect the material nonpublic information known to Defendants. In this action, Plaintiff seeks an award of damages, and prejudgment interest, to Plaintiff and investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) common shares between February 25, 2014 through April 21, 2014.

Shares of Allergan plc (NYSE:AGN) closed on June 30, 2017 at $243.09 per share